We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

129 hedge funds and large institutions have $522M invested in Amphastar Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $489M → $522M (+$33.5M)

0.4% less ownership

Funds ownership: 55.13% → 54.73% (-0.4%)

5% less funds holding

Funds holding: 136 → 129 (-7)

21% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 53

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
129
Holders Change
-7
Holders Change %
-5.15%
% of All Funds
2.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
53
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$9.45M
2
BlackRock
BlackRock
New York
+$4.69M
3
Morgan Stanley
Morgan Stanley
New York
+$4.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.33M
5
Prudential Financial
Prudential Financial
New Jersey
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$5.28M
2
Two Sigma Investments
Two Sigma Investments
New York
-$3.54M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.36M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.25M
5
AL
AJO LP
Pennsylvania
-$2.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
MSL
26
Mackay Shields LLC
New York
$2.32M -$23.4K -1,200 -1%
Public Sector Pension Investment Board (PSP Investments)
27
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.13M +$481K +24,702 +31%
State of New Jersey Common Pension Fund D
28
State of New Jersey Common Pension Fund D
New Jersey
$2.07M -$162K -8,302 -7%
Legal & General Group
29
Legal & General Group
United Kingdom
$2.03M +$13.6K +701 +0.7%
PPA
30
Parametric Portfolio Associates
Washington
$2.02M -$321K -16,509 -14%
Bank of America
31
Bank of America
North Carolina
$2.02M -$320K -16,455 -14%
AllianceBernstein
32
AllianceBernstein
Tennessee
$1.81M +$20.9K +1,073 +1%
Swiss National Bank
33
Swiss National Bank
Switzerland
$1.73M +$38.9K +2,000 +2%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$1.66M -$19 -1 -0%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$1.62M -$31.1K -1,600 -2%
Barclays
36
Barclays
United Kingdom
$1.47M +$80K +4,109 +6%
Citadel Advisors
37
Citadel Advisors
Florida
$1.41M +$315K +16,164 +30%
SGI
38
Summit Global Investments
Utah
$1.25M -$11.9K -613 -1%
SEI Investments
39
SEI Investments
Pennsylvania
$1.11M -$671K -34,500 -38%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$1.11M – – –
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$1.02M -$123K -6,300 -11%
State Board of Administration of Florida Retirement System
42
State Board of Administration of Florida Retirement System
Florida
$1.02M -$277K -14,246 -22%
CS
43
Credit Suisse
Switzerland
$1.02M +$236K +12,109 +32%
WG
44
Winton Group
United Kingdom
$949K -$974K -50,070 -51%
UBS Group
45
UBS Group
Switzerland
$865K +$505K +25,930 +152%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$835K -$2.25M -115,600 -74%
UBS AM
47
UBS AM
Illinois
$826K – – –
Skandinaviska Enskilda Banken (SEB)
48
Skandinaviska Enskilda Banken (SEB)
Sweden
$740K -$459K -23,600 -39%
AQR Capital Management
49
AQR Capital Management
Connecticut
$737K -$308K -15,829 -30%
Canada Life
50
Canada Life
Manitoba, Canada
$710K -$102K -5,216 -13%
1
2
3 4 5

AMPH Hedge Fund Activity: Q4 2020 in Review

129 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2020, worth a combined $522M — up 6.9% from $489M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AMPH and 9 opened new positions — a net loss of 7 holders — while 53 trimmed existing stakes and 42 added.

The largest buyer was Federated Hermes, adding an estimated $9.45M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $5.28M.

  • 129 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2020, down from 136 in Q3 2020.
  • Funds reported $522M of Amphastar Pharmaceuticals stock for Q4 2020, up 6.9% quarter-over-quarter.
  • 9 funds opened new Amphastar Pharmaceuticals positions in Q4 2020 and 16 closed out, a net change of -7 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q4 2020 was Federated Hermes, an estimated $9.45M added.
  • The largest Amphastar Pharmaceuticals seller in Q4 2020 was Fuller & Thaler Asset Management, an estimated $5.28M sold.

Based on aggregated 13F filings for Q4 2020.